Webster, MD, Lynn

• Journal of Opioid Management Vol. 12 No. 4 (2016): July/August - Articles
  Call For Papers - Special Abuse Deterrent Formulation Issue
  Abstract  PDF
• Journal of Opioid Management Vol. 12 No. 6 (2016): November/December - Articles
  A 12-week extension study to assess the safety and tolerability of naloxegol in patients with noncancer pain and opioid-induced constipation
  Abstract
• Journal of Opioid Management Vol. 7 No. 3 (2011): May/June - Review Articles
  Current status and evolving role of abuse-deterrent opioids in managing patients with chronic pain
  Abstract
• Journal of Opioid Management Vol. 6 No. 5 (2010): September/October - Articles
  A double-blind, placebo-controlled study of dual-opioid treatment with the combination of morphine plus oxycodone in patients with acute postoperative pain
  Abstract
• Journal of Opioid Management Vol. 17 No. 7 (2021): Special Issue - "Buprenorphine: Clinical and Public Policy Implications" - Articles
  Atypical opioids and their effect on respiratory drive
  Abstract
• Journal of Opioid Management Vol. 18 No. 2 (2022): March/April - Articles
  Effects of buprenorphine buccal film and oral oxycodone on pupil diameter in a respiratory study
  Abstract  PDF
• Journal of Opioid Management Vol. 10 No. 4 (2014): July/August - Articles
  Review article. Opioid analgesics: Does potency matter?
  Abstract
• Journal of Opioid Management Vol. 7 No. 3 (2011): May/June - Articles
  Efficacy and safety of an extended-release oxycodone (Remoxy®) formulation in patients with moderate to severe osteoarthritic pain
  Abstract
• Journal of Opioid Management Vol. 9 No. 2 (2013): March/April - Articles
  A clinical trial to determine if corelease of morphine and naltrexone from crushed extended-release capsules induces withdrawal in opioid-dependent patients: A descriptive analysis of six patients
  Abstract
• Journal of Opioid Management Vol. 11 No. 6 (2015): November/December - Articles
  Self-reports of prescription opioid abuse and diversion among recreational opioid users in a Canadian and a United States city
  Abstract